4//SEC Filing
SEELEY BRUCE J. 4
Accession 0000891293-19-000009
CIK 0000891293other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:59 PM ET
Size
5.5 KB
Accession
0000891293-19-000009
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2019-02-19+400,000→ 400,000 totalExercise: $0.95Exp: 2029-02-19→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]1/3 of the shares subject to the Option shall vest on the one year anniversary of February 19, 2019, and 1/3 of the shares shall vest annually thereafter on February 19, subject to Reporting Person continuing to be an employee or service provider on each date, such that the Option shall be fully vested on February 19, 2022.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001474462
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:59 PM ET
- Size
- 5.5 KB